Generation Bio Co.

NASDAQ:GBIO

2.16 (USD) • At close November 4, 2024
Bedrijfsnaam Generation Bio Co.
Symbool GBIO
Munteenheid USD
Prijs 2.16
Beurswaarde 144,160,992
Dividendpercentage 0%
52-weken bereik 1.02 - 4.65
Industrie Biotechnology
Sector Healthcare
CEO Dr. Cameron Geoffrey McDonough M.D.
Website https://generationbio.com

An error occurred while fetching data.

Over Generation Bio Co.

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.

Vergelijkbare Aandelen

Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc.

MCRB

0.807 USD

Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc.

XERS

3.22 USD

SOPHiA GENETICS SA logo

SOPHiA GENETICS SA

SOPH

3.75 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

18.94 USD

Zynex, Inc. logo

Zynex, Inc.

ZYXI

8 USD

LianBio logo

LianBio

LIAN

0.319 USD

Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

EWTX

34.48 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)